Contents
Academy · Checklists · CONSORT 2010
CONSORT 2010 Trials Report What Was Found Almost Universally. They Report How Bias Was Controlled Far Less Often.
The 25-item, 37-sub-item CONSORT 2010 checklist for reporting a standard two-group, parallel-design randomised trial. A newer CONSORT 2025 update now exists; check which version your target journal currently requires.
Developed by Kenneth Schulz, Douglas Altman and David Moher for the CONSORT Group, and published in PLoS Medicine in 2010, CONSORT 2010 updated the 1996 and 2001 versions of a checklist built so that readers and systematic reviewers can tell how a trial was randomised, whether it was blinded, and whether every randomised participant was accounted for — the specific omissions methodological research has tied directly to biased trial results.
What it is
Schulz KF, Altman DG, Moher D, for the CONSORT Group. “CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.” PLoS Medicine, 2010;7(3):e1000251. A CONSORT 2025 update (DOI 10.1136/bmj-2024…, PMID 40229553) is now the current EQUATOR Network listing; many journals’ instructions still reference 2010.
Before CONSORT, published trial reports varied so much in completeness that readers often could not tell whether a trial was properly randomised, blinded, or whether all randomised participants were accounted for in the analysis — problems directly linked to biased results. CONSORT gives authors a checklist of items known to be associated with biased or unreliable results when omitted.
Standard two-group, parallel-design randomised controlled trials. Design-specific extensions exist for cluster, non-inferiority, pragmatic, multi-arm and other trial types; this page covers only the core 2010 checklist.
Is this the right tool?
Use it when
Authors of a parallel-group trial report, from protocol through submission; trial statisticians contributing to the write-up; peer reviewers and journal editors assessing completeness. Many journals require a completed, page-referenced checklist as a submission condition.
Not the right tool when
A single-arm or non-randomised intervention study should use a design-specific guideline, not the parallel-group checklist. A cluster, non-inferiority, pragmatic or stepped-wedge trial should use the matching CONSORT extension. A trial’s protocol (as opposed to its results report) should be reported against SPIRIT, not CONSORT.
The 25 items
Grouped under CONSORT 2010’s six section headings; several items have lettered sub-parts.
Title/abstract, Introduction, Methods
| Item | What it requires |
|---|---|
| 1a–1b. Title and abstract | Identify the report as a randomised trial in the title; give a structured summary of design, methods, results and conclusions. |
| 2a–2b. Introduction | Scientific background and rationale; specific objectives or hypotheses. |
| 3–12. Methods | Trial design and allocation ratio; eligibility criteria and settings; interventions in replicable detail; pre-specified outcomes; sample-size rationale and interim-analysis plans; random-sequence generation, type and concealment mechanism; who generated/enrolled/assigned; blinding; statistical methods for primary, secondary and additional analyses. |
Results, Discussion, Other information
| Item | What it requires |
|---|---|
| 13–19. Results | Participant flow for each group with a flow diagram; recruitment and follow-up dates; baseline characteristics table; numbers analysed and whether by assigned group; effect sizes with precision for each outcome; other analyses performed; harms in each group. |
| 20–22. Discussion | Trial limitations and sources of bias; generalisability; an interpretation balancing benefits and harms against other evidence. |
| 23–25. Other information | Trial registration number and registry; where the full protocol can be accessed; funding sources and the funders’ role. |
Applying it, with the evidence
CONSORT is one of the most heavily audited reporting guidelines in existence, and the audits keep finding the same split: outcome reporting approaches 100% while randomisation-sequence generation and concealment — the items most tied to selection bias — remain the worst-reported by a wide margin, even decades after CONSORT made them mandatory checklist entries.
The core checklist is near-universally required by biomedical and clinical journals for standard two-group parallel trials, across vaccine research, pharmacology, surgery, oncology and general medicine; design-specific extensions extend it to cluster, non-inferiority, pragmatic and multi-arm trials.
In order
Where it goes right
With it — no verifiable example found
Our research for this page did not turn up a named, checkable published paper that explicitly credits this checklist for a well-reported study. Rather than invent one, we are saying so. If you know of one, the EQUATOR Network page for this guideline is the place such examples tend to get collected.
Common mistakes
- The randomisation-and-concealment items are the most consistently under-reported, even in trials that score well overall. Name the exact sequence-generation method and concealment mechanism, not a general description.
- A CONSORT checklist citation is not evidence of compliant reporting on its own. Audits repeatedly find trials that completed the checklist still omitting the specific mechanism detail it asks for.
- Flow diagrams get omitted even in otherwise compliant submissions. Build it as a required figure, not an optional extra.
Where it falls short
Where trials fall short — Ngah et al. 2020, 124 tuberculosis vaccine trials
Reviewing 124 TB vaccine trials (1990–2018): mean overall CONSORT adherence was 67.3% (range 26.5–97.1%), and only 46 trials (37%) met an “adequate reporting” threshold of 75% of applicable items. Outcome-reporting items scored 96–100%, while who generated the random allocation sequence scored 16.9%, planned interim analyses 13.7%, and how the sequence was generated 37.9%. Adequate reporting rose sharply over time — 4.4% of trials in 1990–2000 to 53.4% in 2011–2018 — showing CONSORT’s adoption working, slowly.
Ngah VD, Mazingisa AV, Zunza M, Wiysonge CS. “A Review of Adherence and Predictors of Adherence to the CONSORT Statement in the Reporting of Tuberculosis Vaccine Trials.” Vaccines, 2020;8(4):770. doi.org/10.3390/vaccines8040770.
Common questions
CONSORT 2025 is now the current EQUATOR Network-listed version, but many journals’ instructions and in-progress protocols still reference 2010. Check the specific target journal’s current requirement rather than assuming either is universal.
The core logic still applies, but consult the CONSORT extension for multi-arm parallel-group trials for guidance on adapting specific items such as sample size and outcome reporting across more than two groups.
No. Item 23 requires authors to report the trial’s registration number and registry, assuming registration already happened; it discloses registration, it does not substitute for it.
References and sources
- Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. PLoS Medicine, 2010;7(3):e1000251. read 8 October 2026. doi.org/10.1371/journal.pmed.1000251
- EQUATOR Network. CONSORT reporting guideline (lists CONSORT 2010 as superseded by CONSORT 2025). read 8 October 2026. equator-network.org
Each source carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 8). CONSORT 2010 Trials Report What Was Found Almost Universally. They Report How Bias Was Controlled Far Less Often. Pubrica. https://pubrica.com/insights/checklist/consort-2010-reporting-checklist/
Pubrica Academy. “CONSORT 2010 Trials Report What Was Found Almost Universally. They Report How Bias Was Controlled Far Less Often.” Pubrica, 8 Oct. 2026, pubrica.com/insights/checklist/consort-2010-reporting-checklist/.
Pubrica Academy (2026) CONSORT 2010 Trials Report What Was Found Almost Universally. They Report How Bias Was Controlled Far Less Often. Pubrica. Available at: https://pubrica.com/insights/checklist/consort-2010-reporting-checklist/ (Accessed: 15 October 2026).
Pubrica Academy. “CONSORT 2010 Trials Report What Was Found Almost Universally. They Report How Bias Was Controlled Far Less Often.” Pubrica. October 8, 2026. https://pubrica.com/insights/checklist/consort-2010-reporting-checklist/
Pubrica Academy, ‘CONSORT 2010 Trials Report What Was Found Almost Universally. They Report How Bias Was Controlled Far Less Often’ (Pubrica, 8 October 2026) <https://pubrica.com/insights/checklist/consort-2010-reporting-checklist/> accessed 15 October 2026.
Pubrica Academy. CONSORT 2010 Trials Report What Was Found Almost Universally. They Report How Bias Was Controlled Far Less Often. [Internet]. Pubrica; 2026 Oct 8 [cited 2026 Oct 15]. Available from: https://pubrica.com/insights/checklist/consort-2010-reporting-checklist/
Pubrica Academy, “CONSORT 2010 Trials Report What Was Found Almost Universally. They Report How Bias Was Controlled Far Less Often,” Pubrica, Oct. 8, 2026. [Online]. Available: https://pubrica.com/insights/checklist/consort-2010-reporting-checklist/
@misc{consort_2010_reporting_checklist_2026,
author = {{Pubrica Academy}},
title = {CONSORT 2010 Trials Report What Was Found Almost Universally. They Report How Bias Was Controlled Far Less Often},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/insights/checklist/consort-2010-reporting-checklist/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Pubrica AcademyWritten and maintained by the subject matter experts of Pubrica who do this work. Articles are revised when the standard underneath them moves, and each one carries the date it was last checked.
How Pubrica helps
Pubrica’s trial-reporting team cross-checks every reported outcome against the registered protocol and builds the participant flow diagram as a dedicated figure before submission.